Tag: development
-
Child TB deaths set to fall as Kenya launches new drugs
By Katy Migiro NAIROBI (Thomson Reuters Foundation) – More children are likely to survive tuberculosis, the leading infectious disease killer, after Kenya introduces child-friendly medicines on Oct. 1 – the first country in the world to do so. Some 155,000 children with TB are set to benefit across 18 countries that have already ordered the…
-
Child TB deaths set to fall as Kenya launches new drugs
By Katy Migiro NAIROBI (Thomson Reuters Foundation) – More children are likely to survive tuberculosis, the leading infectious disease killer, after Kenya introduces child-friendly medicines on Oct. 1 – the first country in the world to do so. Some 155,000 children with TB are set to benefit across 18 countries that have already ordered the…
-
Mother sues U.S. hospital for discriminating against dead transgender son
The mother of a transgender boy filed a lawsuit against a U.S. hospital on Monday claiming its medical staff repeatedly addressed her son – who later committed suicide – as a girl. In the landmark case, Katharine Prescott argues the Rady Children’s Hospital-San Diego (RCHSD) in California discriminated against her transgender son based on his…
-
Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) – People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to…
-
Kite immunotherapy drug helps blood cancer patients in study
(Reuters) – Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of…
-
More U.S. babies born addicted to opiates like heroin
By Lisa Rapaport (Reuters Health) – The proportion of U.S. babies born suffering from withdrawal syndrome after exposure to heroin or prescription opiates in utero has more than doubled in less than a decade, a study suggests. Researchers focused on what’s known as neonatal abstinence syndrome, a condition akin to withdrawal that develops when babies…
-
Zafgen to scrap lead obesity drug, shares slide
(Reuters) – Zafgen Inc said it was suspending the development of its lead obesity drug, beloranib, more than six months after the U.S. Food and Drug Administration asked the company to halt all tests on the drug following the death of two patients. Zafgen’s shares tumbled more than 40 percent in extended trading on Tuesday…
-
Physician-assisted suicide, euthanasia: increasingly legal but still rare
By Andrew M. Seaman (Reuters Health) – Legalized euthanasia and physician-assisted suicide are mainly used by patients with cancer, but remain rare, according to a new analysis of such programs. In the last year alone, California has legalized physician-assisted suicide, Canada legalized both physician-assisted suicide and euthanasia, and Colombia performed its first legal euthanasia, said…